Back to Search
Start Over
Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials.
- Source :
-
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2017 Oct 09; Vol. 2, pp. 17054. Date of Electronic Publication: 2017 Oct 09 (Print Publication: 2017). - Publication Year :
- 2017
-
Abstract
- Competing Interests: The authors declare no conflict of interest.
Details
- Language :
- English
- ISSN :
- 2095-9907
- Volume :
- 2
- Database :
- MEDLINE
- Journal :
- Signal transduction and targeted therapy
- Publication Type :
- Report
- Accession number :
- 29263931
- Full Text :
- https://doi.org/10.1038/sigtrans.2017.54